|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.08 USD | -1.99% |
|
+0.83% | +6.89% |
| 23/12 | Fulgent Genetics to Acquire Bako Diagnostics and StrataDx for $55.5 Million | MT |
| 11/11 | Fulgent Genetics, Inc. Presents at UBS Global Healthcare Conference 2025, Nov-10-2025 05:00 PM |
| Capitalization | 87Cr 75Cr 69Cr 65Cr 120.32Cr 7.89TCr 129.3Cr 799.25Cr 314.79Cr 3.76TCr 325.52Cr 318.84Cr 14TCr | P/E ratio 2025 * |
-19.2x | P/E ratio 2026 * | -16.8x |
|---|---|---|---|---|---|
| Enterprise value | 7.28Cr 6.26Cr 5.81Cr 5.42Cr 10Cr 661.95Cr 11Cr 67Cr 26Cr 315.17Cr 27Cr 27Cr 1.15TCr | EV / Sales 2025 * |
0.22x | EV / Sales 2026 * | 0.25x |
| Free-Float |
62.05% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Fulgent Genetics, Inc.
More recommendations
More press releases
| 02/22/02 | Tres ETFs en la nube | |
| 31/22/31 | Trois ETFs dans le cloud |
| 1 day | -1.99% | ||
| 1 week | +0.83% | ||
| Current month | +6.89% | ||
| 1 month | +0.07% | ||
| 3 months | +23.81% | ||
| 6 months | +57.93% | ||
| Current year | +6.89% |
| 1 week | 27.39 | 28.95 | |
| 1 month | 25.07 | 28.95 | |
| Current year | 25.07 | 28.95 | |
| 1 year | 14.57 | 31.04 | |
| 3 years | 14.57 | 44.09 | |
| 5 years | 14.57 | 189.89 | |
| 10 years | 2.72 | 189.89 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xie
PSD | President | 59 | 03/05/2022 |
Ming Hsieh
CEO | Chief Executive Officer | 70 | 13/05/2016 |
Paul Kim
DFI | Director of Finance/CFO | 58 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Hsieh
CHM | Chairman | 70 | 01/09/2016 |
Linda Marsh
BRD | Director/Board Member | 76 | 01/08/2019 |
Michael Nohaile
BRD | Director/Board Member | 57 | 01/08/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.99% | +0.83% | +64.21% | -15.27% | 87Cr | ||
| -3.78% | -1.31% | +46.03% | +464.30% | 3.2TCr | ||
| -0.77% | +2.99% | -16.50% | -26.46% | 767.76Cr | ||
| -2.74% | -9.22% | +18.59% | +252.13% | 548.63Cr | ||
| -1.10% | -20.17% | +55.56% | +624.59% | 312.4Cr | ||
| -1.04% | +0.17% | -1.90% | +30.00% | 257.45Cr | ||
| -12.86% | +16.34% | +137.50% | -5.39% | 221.62Cr | ||
| -0.12% | -3.27% | +26.05% | -61.01% | 216.73Cr | ||
| 0.00% | +2.50% | - | - | 180.66Cr | ||
| -0.31% | -2.81% | -9.99% | +8.30% | 165.49Cr | ||
| Average | -2.47% | -3.95% | +35.50% | +141.24% | 595.62Cr | |
| Weighted average by Cap. | -3.00% | -2.62% | +34.92% | +310.21% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 32Cr 28Cr 26Cr 24Cr 45Cr 2.95TCr 48Cr 298.84Cr 117.7Cr 1.4TCr 121.71Cr 119.21Cr 5.13TCr | 36Cr 31Cr 28Cr 27Cr 49Cr 3.24TCr 53Cr 328.07Cr 129.21Cr 1.54TCr 133.62Cr 130.87Cr 5.63TCr |
| Net income | -4.9Cr -4.21Cr -3.9Cr -3.65Cr -6.79Cr -445.08Cr -7.3Cr -45Cr -18Cr -211.91Cr -18Cr -18Cr -774.4Cr | -6.16Cr -5.29Cr -4.91Cr -4.59Cr -8.54Cr -559.62Cr -9.17Cr -57Cr -22Cr -266.44Cr -23Cr -23Cr -973.68Cr |
| Net Debt | -80Cr -68Cr -63Cr -59Cr -110.23Cr -7.23TCr -118.45Cr -732.18Cr -288.37Cr -3.44TCr -298.21Cr -292.08Cr -13TCr | -78Cr -67Cr -62Cr -58Cr -107.75Cr -7.06TCr -115.78Cr -715.7Cr -281.88Cr -3.36TCr -291.5Cr -285.51Cr -12TCr |
More financial data
* Estimated data
Employees
1,313
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | 28.08 $ | -1.99% | 3,10,493 |
| 15/26/15 | 28.65 $ | +2.43% | 2,18,316 |
| 14/26/14 | 27.97 $ | -1.38% | 2,76,691 |
| 13/26/13 | 28.36 $ | +0.71% | 1,92,899 |
| 12/26/12 | 28.16 $ | +1.11% | 2,17,510 |
Delayed Quote Nasdaq, January 17, 2026 at 02:30 am IST
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
28.08USD
Average target price
33.67USD
Spread / Average Target
+19.90%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FLGT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















